Related Experiment Video
Updated: Jun 25, 2025

07:50
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
2.7K
Histotripsy and Catheter-Directed Lytic: Efficacy in Highly Retracted Porcine Clots In Vitro
Shumeng Yang1, Chadi Zemzemi2, Daniel Suarez Escudero2
1Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, USA.
Ultrasound in Medicine & Biology
|May 22, 2024
Summary
Histotripsy, a non-invasive ultrasound therapy, significantly enhanced the breakdown of deep vein thrombosis (DVT) clots. Combining histotripsy with recombinant tissue plasminogen activator (rt-PA) showed superior clot lysis in a flow model.
Area of Science:
- Biomedical Engineering
- Interventional Radiology
- Cardiovascular Research
Background:
- Standard deep vein thrombosis (DVT) treatments face challenges with chronic, resistant thrombi.
- Histotripsy, utilizing mechanical cavitation, shows promise in augmenting thrombolytic therapies.
Purpose of the Study:
- To evaluate the efficacy of histotripsy in enhancing recombinant tissue plasminogen activator (rt-PA) mediated thrombolysis.
- To assess histotripsy's effectiveness on highly retracted porcine clots in an in vitro DVT flow model.
Main Methods:
- Porcine clots were treated with saline, rt-PA, histotripsy, or combinations with DEFINITY.
- Histotripsy employed 1.5 MHz pulses at 33.2 MPa peak negative pressure and 40 Hz pulse repetition frequency.
- B-Mode and passive cavitation imaging monitored bubble activity during treatment.
Main Results:
- Histotripsy with or without rt-PA demonstrated superior thrombolytic efficacy compared to controls.
- Histotripsy combined with rt-PA achieved 86.1% flow recovery, significantly outperforming histotripsy with saline (61.7%).
- The addition of DEFINITY did not improve thrombolytic efficacy or cavitation dose.
Conclusions:
- Histotripsy effectively enhances thrombolytic efficacy for DVT, even with chronic clots.
- The combination of histotripsy and rt-PA shows significant potential for DVT treatment in a physiological flow environment.

